Mohamed, A.; Azmi, A.S.; Asa, S.L.; Tirumani, S.H.; Mahipal, A.; Cjakrabarti, S.; Bajor, D.; Selfridge, J.E.; Kaseb, A.O.
Thymoquinone Plus Immunotherapy in Extra-Pulmonary Neuroendocrine Carcinoma: Case Series for a Novel Combination. Curr. Oncol. 2022, 29, 9018-9030.
https://doi.org/10.3390/curroncol29110707
AMA Style
Mohamed A, Azmi AS, Asa SL, Tirumani SH, Mahipal A, Cjakrabarti S, Bajor D, Selfridge JE, Kaseb AO.
Thymoquinone Plus Immunotherapy in Extra-Pulmonary Neuroendocrine Carcinoma: Case Series for a Novel Combination. Current Oncology. 2022; 29(11):9018-9030.
https://doi.org/10.3390/curroncol29110707
Chicago/Turabian Style
Mohamed, Amr, Asfar S. Azmi, Sylvia L. Asa, Sree Harsha Tirumani, Amit Mahipal, Sakti Cjakrabarti, David Bajor, J. Eva Selfridge, and Ahmed O. Kaseb.
2022. "Thymoquinone Plus Immunotherapy in Extra-Pulmonary Neuroendocrine Carcinoma: Case Series for a Novel Combination" Current Oncology 29, no. 11: 9018-9030.
https://doi.org/10.3390/curroncol29110707
APA Style
Mohamed, A., Azmi, A. S., Asa, S. L., Tirumani, S. H., Mahipal, A., Cjakrabarti, S., Bajor, D., Selfridge, J. E., & Kaseb, A. O.
(2022). Thymoquinone Plus Immunotherapy in Extra-Pulmonary Neuroendocrine Carcinoma: Case Series for a Novel Combination. Current Oncology, 29(11), 9018-9030.
https://doi.org/10.3390/curroncol29110707